Drug
Cefaclor
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Red Blood Cell Sedimentation Rate Increased | 43 | 53.2 | 54.7 | signal |
| 2 | Platelet Count Increased | 50 | 52.5 | 54.2 | signal |
| 3 | Secretion Discharge | 41 | 45.5 | 46.7 | signal |
| 4 | Toxic Epidermal Necrolysis | 40 | 36.3 | 37.3 | signal |
| 5 | Eye Inflammation | 22 | 31.9 | 32.4 | signal |
| 6 | Clostridium Difficile Infection | 41 | 25.9 | 26.6 | signal |
| 7 | Lymphocyte Count Decreased | 31 | 24.0 | 24.5 | signal |
| 8 | Paralysis | 24 | 22.9 | 23.2 | signal |
| 9 | Skin Infection | 18 | 22.1 | 22.3 | signal |
| 10 | Paraesthesia Oral | 23 | 21.9 | 22.2 | signal |
| 11 | Helicobacter Infection | 16 | 21.5 | 21.7 | signal |
| 12 | Staphylococcal Infection | 50 | 20.7 | 21.3 | signal |
| 13 | Drug Eruption | 26 | 20.2 | 20.5 | signal |
| 14 | Muscle Tightness | 23 | 19.5 | 19.7 | signal |
| 15 | Therapeutic Product Effect Incomplete | 95 | 18.4 | 19.5 | signal |
| 16 | Obesity | 21 | 18.0 | 18.2 | signal |
| 17 | Drug Hypersensitivity | 252 | 17.8 | 21.1 | signal |
| 18 | Pemphigus | 16 | 17.6 | 17.8 | signal |
| 19 | Erythema Multiforme | 11 | 16.1 | 16.3 | signal |
| 20 | Liver Injury | 28 | 15.8 | 16.1 | signal |
| 21 | Iron Deficiency Anaemia | 10 | 14.9 | 15.0 | signal |
| 22 | End Stage Renal Disease | 20 | 14.9 | 15.0 | signal |
| 23 | Hypocalcaemia | 20 | 14.5 | 14.7 | signal |
| 24 | Renal Tubular Necrosis | 10 | 13.9 | 14.0 | signal |
| 25 | Neutrophil Count Decreased | 41 | 13.8 | 14.2 | signal |
| 26 | Drug Intolerance | 96 | 13.6 | 14.5 | signal |
| 27 | Gastroenteritis | 14 | 13.1 | 13.3 | signal |
| 28 | Rash Erythematous | 45 | 13.1 | 13.5 | signal |
| 29 | Mouth Ulceration | 20 | 13.0 | 13.2 | signal |
| 30 | Pericarditis | 15 | 12.3 | 12.4 | signal |
| 31 | Angioedema | 39 | 12.1 | 12.4 | signal |
| 32 | Stevens-johnson Syndrome | 19 | 11.7 | 11.8 | signal |
| 33 | Disseminated Intravascular Coagulation | 12 | 11.6 | 11.7 | signal |
| 34 | Chronic Kidney Disease | 64 | 11.4 | 11.9 | signal |
| 35 | Hyperlipidaemia | 10 | 11.4 | 11.5 | signal |
| 36 | Irritable Bowel Syndrome | 17 | 10.9 | 11.0 | signal |
| 37 | Hypokalaemia | 36 | 10.7 | 11.0 | signal |
| 38 | Type 2 Diabetes Mellitus | 26 | 10.5 | 10.7 | signal |
| 39 | Viral Infection | 25 | 10.3 | 10.4 | signal |
| 40 | Septic Shock | 32 | 10.1 | 10.3 | signal |
| 41 | Infection | 106 | 10.1 | 10.7 | signal |
| 42 | Alanine Aminotransferase Increased | 45 | 10.0 | 10.3 | signal |
| 43 | Knee Operation | 7 | 9.9 | 9.9 | signal |
| 44 | Candida Infection | 12 | 9.8 | 9.9 | signal |
| 45 | Aspartate Aminotransferase Increased | 38 | 9.8 | 10.0 | signal |
| 46 | Carpal Tunnel Syndrome | 10 | 9.7 | 9.8 | signal |
| 47 | Systemic Lupus Erythematosus | 25 | 9.7 | 9.8 | signal |
| 48 | Anaphylactic Shock | 18 | 9.6 | 9.7 | signal |
| 49 | Cystitis | 22 | 9.4 | 9.5 | signal |
| 50 | Shock | 15 | 9.0 | 9.1 | signal |
| 51 | Osteopenia | 10 | 9.0 | 9.0 | signal |
| 52 | Agranulocytosis | 12 | 8.9 | 8.9 | signal |
| 53 | Dry Eye | 31 | 8.8 | 8.9 | signal |
| 54 | Gamma-glutamyltransferase Increased | 14 | 8.6 | 8.7 | signal |
| 55 | Speech Disorder | 33 | 8.6 | 8.8 | signal |
| 56 | Skin Lesion | 17 | 8.5 | 8.6 | signal |
| 57 | Rotator Cuff Syndrome | 8 | 8.5 | 8.5 | signal |
| 58 | Bacterial Infection | 11 | 8.1 | 8.2 | signal |
| 59 | Economic Problem | 9 | 8.0 | 8.0 | signal |
| 60 | Hyperkalaemia | 20 | 7.8 | 7.9 | signal |
| 61 | Anaphylactic Reaction | 31 | 7.7 | 7.9 | signal |
| 62 | Rash Maculo-papular | 12 | 7.4 | 7.5 | signal |
| 63 | Hepatotoxicity | 12 | 7.4 | 7.5 | signal |
| 64 | Wound | 15 | 7.4 | 7.4 | signal |
| 65 | Nerve Injury | 6 | 7.4 | 7.4 | signal |
| 66 | Hepatic Failure | 16 | 7.2 | 7.3 | signal |
| 67 | Device Related Infection | 8 | 7.1 | 7.1 | signal |
| 68 | White Blood Cell Count Decreased | 56 | 7.1 | 7.3 | signal |
| 69 | Hepatic Function Abnormal | 19 | 7.0 | 7.1 | signal |
| 70 | Lower Respiratory Tract Infection | 23 | 6.9 | 7.0 | signal |
| 71 | Myelosuppression | 17 | 6.8 | 6.9 | signal |
| 72 | Hypotonia | 5 | 6.8 | 6.8 | signal |
| 73 | Dysphonia | 29 | 6.8 | 6.9 | signal |
| 74 | Rash Macular | 17 | 6.7 | 6.7 | signal |
| 75 | Neutrophil Count Increased | 5 | 6.7 | 6.7 | signal |
| 76 | Rash Pruritic | 26 | 6.6 | 6.7 | signal |
| 77 | Dermatitis Allergic | 6 | 6.6 | 6.6 | signal |
| 78 | Impaired Gastric Emptying | 6 | 6.4 | 6.5 | signal |
| 79 | Blood Triglycerides Increased | 8 | 6.2 | 6.2 | signal |
| 80 | Joint Range Of Motion Decreased | 6 | 6.1 | 6.2 | signal |
| 81 | Restless Legs Syndrome | 8 | 6.0 | 6.0 | signal |
| 82 | Blood Lactate Dehydrogenase Increased | 7 | 6.0 | 6.0 | signal |
| 83 | Vasculitis | 5 | 5.9 | 5.9 | signal |
| 84 | Tubulointerstitial Nephritis | 8 | 5.8 | 5.9 | signal |
| 85 | Urticaria | 71 | 5.8 | 6.1 | signal |
| 86 | Lymphopenia | 6 | 5.8 | 5.9 | signal |
| 87 | Abortion Induced | 4 | 5.8 | 5.8 | signal |
| 88 | Polyneuropathy | 5 | 5.7 | 5.8 | signal |
| 89 | Gallbladder Disorder | 7 | 5.3 | 5.4 | signal |
| 90 | Toothache | 7 | 5.3 | 5.3 | signal |
| 91 | Tendonitis | 6 | 5.3 | 5.3 | signal |
| 92 | Rhabdomyolysis | 16 | 5.3 | 5.3 | signal |
| 93 | Anorexia | 5 | 5.2 | 5.2 | signal |
| 94 | Transfusion | 4 | 5.2 | 5.2 | signal |
| 95 | Diabetic Ketoacidosis | 9 | 5.1 | 5.2 | signal |
| 96 | Extrapyramidal Disorder | 9 | 4.9 | 4.9 | signal |
| 97 | Skin Reaction | 5 | 4.9 | 4.9 | signal |
| 98 | Eyelid Oedema | 4 | 4.7 | 4.7 | signal |
| 99 | Neuroleptic Malignant Syndrome | 4 | 4.6 | 4.6 | signal |
| 100 | Cytomegalovirus Infection | 5 | 4.1 | 4.1 | signal |
| 101 | Eosinophilia | 5 | 3.9 | 3.9 | signal |
| 102 | Synovitis | 5 | 3.8 | 3.8 | signal |
| 103 | Premature Delivery | 4 | 3.4 | 3.4 | signal |
| 104 | Hepatocellular Injury | 3 | 2.9 | 2.9 | no signal |
| 105 | Tardive Dyskinesia | 6 | 2.9 | 2.9 | signal |
| 106 | Drug Reaction With Eosinophilia And Systemic Symptoms | 5 | 2.7 | 2.7 | no signal |
| 107 | Multiple Fractures | 3 | 2.5 | 2.5 | no signal |
| 108 | Premature Baby | 5 | 2.3 | 2.3 | no signal |
| 109 | Suicide Attempt | 10 | 2.2 | 2.3 | signal |
| 110 | Foetal Exposure During Pregnancy | 13 | 2.2 | 2.2 | signal |
| 111 | Menorrhagia | 3 | 2.1 | 2.1 | no signal |
| 112 | Drug Exposure During Pregnancy | 4 | 1.6 | 1.6 | no signal |
| 113 | Intentional Overdose | 7 | 1.5 | 1.5 | no signal |